h-phe-gln-val-val-cys(npys)-gly-nh2

[ Density]:
1.38g/cm3

[ Boiling Point ]:
1152.3ºC at 760mmHg

[ Molecular Formula ]:
C₃₄H₄₈N₁₀O₉S

[ Molecular Weight ]:
772.87200

[ Flash Point ]:
650.7ºC

[ Exact Mass ]:
772.33300

[ PSA ]:
341.71000

[ LogP ]:
3.34870

[ Vapour Pressure ]:
0mmHg at 25°C

[ Index of Refraction ]:
1.63

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.

Pept. Res. 7 , 32-35, (1994)

Thrombin-induced platelet aggregation has been suggested to play an important role in reocclusion following thrombolytic therapy or angioplasty for treatment of myocardial infarction. We previously de...

Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.

Eur. J. Biochem. 214 , 233-241, (1993)

Thrombin-induced platelet aggregation has been suggested to play an important role in reocclusion following thrombolytic therapy of angioplasty for treatment of myocardial infarction. We previously de...

Specificity of the sequence in Phe-Gln-Val-Val-Cys (-3-nitro-2-pyridinesulfenyl)-Gly-NH2--a selective inhibitor of thrombin-induced platelet aggregation.

Thromb. Res. 72 , 183, (1993)

Thrombin-induced platelet aggregation is mediated in part by the intracellularly activated calpain expressed onto the external side of the membrane. We have previously shown that P1, Phe-Gln-Val-Val-C...

More Articles